EC Healthcare signs inaugural double-tranche facility linked to sustainability, the first of its kind in the healthcare industry in Hong Kong

HONG KONG, June 21, 2022 – (ACN Newswire) – – EC Health (the “Company”, which together with its subsidiaries is referred to as the “Group”, stock code SEHK: 2138), the largest non-hospital medical group in hong kong*, is pleased to announce the signing of its first sustainability-related facility (“SLL Facility”) totaling HK$700 million with The Hongkong and Shanghai Banking Corporation Limited (“HSBC”) as sole lender and structuring bank.

The first two-slice SLL facility is the first of its kind for a healthcare provider in hong kong, complementing the Group’s established status as an industry pioneer and reaffirming the importance of sustainability in the Group’s future growth strategy. The SLL facility is comprised of a revolving credit and a term loan, and the proceeds will be used for working capital.

The Group is committed to The United Nations 2030 Sustainable Development Goals and has developed a number of clear objectives for each of the environmental, social and governance (“ESG”) elements. These include reducing energy consumption, increasing employee engagement and achieving a globally recognized standard of corporate governance.

SGS Hong Kong Limiteda leading sustainability consultancy, acted as ESG consultant on the SLL Facility.

M/s. ada wongExecutive Director, Chief Strategy Officer and Chief Investment Officer of EC Health said: “This first sustainability-related facility is a milestone and represents another bold step in the group’s sustainability journey. As the leading provider of healthcare and medical services in hong kong, this operation reflects the Group’s desire to integrate sustainable development into its core business strategy and to implement best practices in the daily operation of its various brands. We are delighted to align the Group’s funding strategy with a number of hard-hitting ESG objectives, reinforcing our commitment to long-term sustainability. We are excited to set the stage for future sustainable finance transactions in the hong kong health market. »

About EC Health

EC Health is that of Hong Kong leading provider of non-hospital medical services*, relying on its core businesses of preventive and precision medicine, and committed to the development of medical artificial intelligence by integrating its multidisciplinary medical services. This decision, which is based on the Group’s high-end brand image and quality customer services, aims to provide customers with safe and efficient health care and medical services with professionalism. The Group is included in the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.

The Group mainly engages in the provision of one-stop medical and healthcare services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop provider of aesthetic medical solutions DR REBORN which ranked first in hong kong by sales for years, professional hair care center HAIR FOREST, primary care clinics jointly established with re:HEALTH health management center, Hong Kong Professional Vaccine HKPV vaccine center, general outpatient clinic Tencent Doctorwork, the largest one-stop pain management center in Hong Kong and New York Medical Groupcomprehensive dental centers Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Dental Clinic CareHKAI advanced diagnostic and imaging center, reVIVE oncology treatment center, HKMED day procedure center, PREMIER MEDICAL CENTER, SPECIALISTS CENTRAL and NEW MEDICAL CENTER specialist clinic, PRIME CARE pediatric center, specialist in gynecology ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTER, PathLab Medical LaboratoriesVIVID EYE Ophthalmology Center and CE Veterinary Hospital and imaging center.

*According to an independent study conducted by Frost and Sullivan in terms of turnover in 2020 and 2021

For more information, please contact:

iPR Ogilvy Limited

Callis Lau / Lorraine Luk / Charmaine IP

Tel: (852) 2136 6952 / 2169 0467 / 3920 7649

Fax: (852) 3170 6606

Email: [email protected]

Copyright 2022 ACN Newswire. All rights reserved.

© Japan Corporate News, source JCN Press Releases

About Stephen Ewing

Check Also

P-Cure Prepares to Meet Market Demand by Establishing World’s Largest Proton Therapy System Production Facility

P-Cure 360 ​​Degree Gantry-Free Adaptive Proton Therapy System “P-Cure is the only proton therapy provider …